JOHN PETER MCLAUGHLIN Insider Trading
Get free email notifications about insider trading for JOHN PETER MCLAUGHLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN PETER MCLAUGHLIN. JOHN PETER MCLAUGHLIN is a CEO in PDL BIOPHARMA, INC. ($PDLI) and a Director in PDL BIOPHARMA, INC. ($PDLI) and a President, CEO in PDL BIOPHARMA, INC. ($PDLI) and a Director in ROCKWELL MEDICAL, INC. ($RMTI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and an Chief Executive Officer in ANESIVA, INC. ($CGTK) and a President & CEO in ANESIVA, INC. ($CGTK) and a Director in LENSAR, Inc. ($LNSR) and a Director in Adverum Biotechnologies, Inc. ($AAVL).
Address: C/O CORGENTECH INC. 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO 94080 CA
Companies in which JOHN PETER MCLAUGHLIN is an Insider
Adverum Biotechnologies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN PETER MCLAUGHLIN: Director
Holdings: 10,333 shares
Latest Transaction: Feb 17 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ANESIVA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN PETER MCLAUGHLIN: Chief Executive Officer, President & CEO
Holdings: 25,000 shares
Latest Transaction: May 12 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LENSAR, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHN PETER MCLAUGHLIN: Director
Holdings: 0 shares
Latest Transaction: Mar 16 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN PETER MCLAUGHLIN: Director, President, CEO
Holdings: 477,934 shares
Current Value: $1,056,234
Latest Transaction: Dec 22 2020
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ROCKWELL MEDICAL, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN PETER MCLAUGHLIN: Director
Holdings: 86,974 shares
Current Value: $530,541
Latest Transaction: May 20 2020
$RMTI Market Capitalization: $318.95M
$RMTI Previous Close: $6.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN PETER MCLAUGHLIN: Director
Holdings: 39,400 shares
Current Value: $2,395,126
Latest Transaction: May 24 2016
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN PETER MCLAUGHLIN
Sentiment: All, ADVM, CGTK, LNSR, PDLI, RMTI, SGEN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2021 | LNSR | LENSAR, Inc. | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 8.62 | 13,445 | 115,896 | 13,445 | |
| Feb 02 2021 | LNSR | LENSAR, Inc. | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 7.08 | 28,249 | 200,003 | 28,249 | |
| Dec 22 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Sell | S | 2.61 | 277,934 | 724,574 | 200,000 | 477.9 K to 200 K (-58.15 %) |
| Dec 22 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Sell | S | 2.62 | 50,000 | 131,200 | 477,934 | 527.9 K to 477.9 K (-9.47 %) |
| Aug 24 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 3.63 | 118,671 | 430,776 | 118,671 | |
| Aug 24 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 25,826 | 0 | 527,934 | 502.1 K to 527.9 K (+5.14 %) |
| May 20 2020 | RMTI | ROCKWELL MEDICAL, ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 2.04 | 34,024 | 69,409 | 34,024 |